LymphedemaV1, PubMed, Checkpoint, bibRecord, 002814

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Identifieur interne : 002814 ( PubMed/Checkpoint ); précédent : 002813; suivant : 002815

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Auteurs : Paul E. Simonsen [Danemark] ; Erling M. Pedersen ; Rwehumbiza T. Rwegoshora ; Mwelecele N. Malecela ; Yahya A. Derua ; Stephen M. Magesa

Source :

PLoS neglected tropical diseases [ 1935-2735 ] ; 2010.

RBID : pubmed:20532226

Descripteurs français

KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Albendazole (administration et posologie), Animaux, Antigènes d'helminthe (sang), Antiparasitaires (administration et posologie), Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique (), Filariose lymphatique (immunologie), Filariose lymphatique (traitement médicamenteux), Humains, Immunoglobuline G (sang), Ivermectine (administration et posologie), Microfilaria (), Mâle, Nourrisson, Saisons, Tanzanie.
MESH :
- administration et posologie : Albendazole, Antiparasitaires, Ivermectine.
- immunologie : Filariose lymphatique.
- sang : Antigènes d'helminthe, Immunoglobuline G.
- traitement médicamenteux : Filariose lymphatique.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique, Humains, Microfilaria, Mâle, Nourrisson, Saisons, Tanzanie.

English descriptors

KwdEn :
- Adolescent, Adult, Albendazole (administration & dosage), Animals, Antigens, Helminth (blood), Antiparasitic Agents (administration & dosage), Child, Child, Preschool, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (immunology), Elephantiasis, Filarial (prevention & control), Elephantiasis, Filarial (therapy), Female, Humans, Immunoglobulin G (blood), Infant, Ivermectin (administration & dosage), Male, Microfilariae (drug effects), Middle Aged, Seasons, Tanzania.
MESH :
- chemical , administration & dosage : Albendazole, Antiparasitic Agents, Ivermectin.
- chemical , blood : Antigens, Helminth, Immunoglobulin G.
- drug effects : Microfilariae.
- drug therapy : Elephantiasis, Filarial.
- immunology : Elephantiasis, Filarial.
- prevention & control : Elephantiasis, Filarial.
- therapy : Elephantiasis, Filarial.
- Adolescent, Adult, Animals, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Seasons, Tanzania.

Abstract

In most countries of sub-Saharan Africa the control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. Here we present the first detailed study on the effect of 3 repeated MDAs with this drug combination, as implemented by the Tanzanian National Lymphatic Filariasis Elimination Programme (NLFEP).

DOI: 10.1371/journal.pntd.0000696
PubMed: 20532226

Affiliations:

Danemark

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002A47
to stream PubMed, to step Curation: 002A47

Links to Exploration step

pubmed:20532226

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.</title>
<author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
<affiliation wicri:level="1"><nlm:affiliation>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark. pesi@life.ku.dk</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg</wicri:regionArea>
<wicri:noRegion>Frederiksberg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pedersen, Erling M" sort="Pedersen, Erling M" uniqKey="Pedersen E" first="Erling M" last="Pedersen">Erling M. Pedersen</name>
</author>
<author><name sortKey="Rwegoshora, Rwehumbiza T" sort="Rwegoshora, Rwehumbiza T" uniqKey="Rwegoshora R" first="Rwehumbiza T" last="Rwegoshora">Rwehumbiza T. Rwegoshora</name>
</author>
<author><name sortKey="Malecela, Mwelecele N" sort="Malecela, Mwelecele N" uniqKey="Malecela M" first="Mwelecele N" last="Malecela">Mwelecele N. Malecela</name>
</author>
<author><name sortKey="Derua, Yahya A" sort="Derua, Yahya A" uniqKey="Derua Y" first="Yahya A" last="Derua">Yahya A. Derua</name>
</author>
<author><name sortKey="Magesa, Stephen M" sort="Magesa, Stephen M" uniqKey="Magesa S" first="Stephen M" last="Magesa">Stephen M. Magesa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20532226</idno>
<idno type="pmid">20532226</idno>
<idno type="doi">10.1371/journal.pntd.0000696</idno>
<idno type="wicri:Area/PubMed/Corpus">002A47</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A47</idno>
<idno type="wicri:Area/PubMed/Curation">002A47</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A47</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A47</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A47</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.</title>
<author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
<affiliation wicri:level="1"><nlm:affiliation>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark. pesi@life.ku.dk</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg</wicri:regionArea>
<wicri:noRegion>Frederiksberg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pedersen, Erling M" sort="Pedersen, Erling M" uniqKey="Pedersen E" first="Erling M" last="Pedersen">Erling M. Pedersen</name>
</author>
<author><name sortKey="Rwegoshora, Rwehumbiza T" sort="Rwegoshora, Rwehumbiza T" uniqKey="Rwegoshora R" first="Rwehumbiza T" last="Rwegoshora">Rwehumbiza T. Rwegoshora</name>
</author>
<author><name sortKey="Malecela, Mwelecele N" sort="Malecela, Mwelecele N" uniqKey="Malecela M" first="Mwelecele N" last="Malecela">Mwelecele N. Malecela</name>
</author>
<author><name sortKey="Derua, Yahya A" sort="Derua, Yahya A" uniqKey="Derua Y" first="Yahya A" last="Derua">Yahya A. Derua</name>
</author>
<author><name sortKey="Magesa, Stephen M" sort="Magesa, Stephen M" uniqKey="Magesa S" first="Stephen M" last="Magesa">Stephen M. Magesa</name>
</author>
</analytic>
<series><title level="j">PLoS neglected tropical diseases</title>
<idno type="eISSN">1935-2735</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Albendazole (administration & dosage)</term>
<term>Animals</term>
<term>Antigens, Helminth (blood)</term>
<term>Antiparasitic Agents (administration & dosage)</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (immunology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Elephantiasis, Filarial (therapy)</term>
<term>Female</term>
<term>Humans</term>
<term>Immunoglobulin G (blood)</term>
<term>Infant</term>
<term>Ivermectin (administration & dosage)</term>
<term>Male</term>
<term>Microfilariae (drug effects)</term>
<term>Middle Aged</term>
<term>Seasons</term>
<term>Tanzania</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Albendazole (administration et posologie)</term>
<term>Animaux</term>
<term>Antigènes d'helminthe (sang)</term>
<term>Antiparasitaires (administration et posologie)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (immunologie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Immunoglobuline G (sang)</term>
<term>Ivermectine (administration et posologie)</term>
<term>Microfilaria ()</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Saisons</term>
<term>Tanzanie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term>
<term>Antiparasitic Agents</term>
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antigens, Helminth</term>
<term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term>
<term>Antiparasitaires</term>
<term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Microfilariae</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Antigènes d'helminthe</term>
<term>Immunoglobuline G</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Animals</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Seasons</term>
<term>Tanzania</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Microfilaria</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Saisons</term>
<term>Tanzanie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In most countries of sub-Saharan Africa the control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. Here we present the first detailed study on the effect of 3 repeated MDAs with this drug combination, as implemented by the Tanzanian National Lymphatic Filariasis Elimination Programme (NLFEP).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20532226</PMID>
<DateCreated><Year>2010</Year>
<Month>06</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>09</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>4</Volume>
<Issue>6</Issue>
<PubDate><Year>2010</Year>
<Month>Jun</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>PLoS neglected tropical diseases</Title>
<ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.</ArticleTitle>
<Pagination><MedlinePgn>e696</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0000696</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In most countries of sub-Saharan Africa the control of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. Here we present the first detailed study on the effect of 3 repeated MDAs with this drug combination, as implemented by the Tanzanian National Lymphatic Filariasis Elimination Programme (NLFEP).</AbstractText>
<AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">Infection and transmission was monitored during a five-year period (one pre-intervention and four post-intervention years) in a highly endemic community (Kirare village) in north-eastern Tanzania. The vectors were Anopheles gambiae, An. funestus and Cx. quinquefasciatus. After start of intervention, human microfilaraemia initially decreased rapidly and statistically significant (prevalence by 21.2% and 40.4%, and mean intensity by 48.4% and 73.7%, compared to pre-treatment values after the first and second MDA, respectively), but thereafter the effect levelled off. The initial decrease in microfilaraemia led to significant decreases in vector infection and vector infectivity rates and thus to a considerable reduction in transmission (by 74.3% and 91.3% compared to pre-treatment level after first and second MDA, respectively). However, the decrease in infection and infectivity rates subsequently also levelled off, and low-level transmission was still noted after the third MDA. The MDAs had limited effect on circulating filarial antigens and antibody response to Bm14.</AbstractText>
<AbstractText Label="CONCLUSION/SIGNIFICANCE" NlmCategory="CONCLUSIONS">Critical issues that may potentially explain the observed waning effect of the MDAs in the later study period include the long intervals between MDAs and a lower than optimal treatment coverage. The findings highlight the importance of ongoing surveillance for monitoring the progress of LF control programmes, and it calls for more research into the long-term effect of repeated ivermectin/albendazole MDAs (including the significance of treatment intervals and compliance), in order to optimize efforts to control LF in sub-Saharan Africa.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simonsen</LastName>
<ForeName>Paul E</ForeName>
<Initials>PE</Initials>
<AffiliationInfo><Affiliation>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark. pesi@life.ku.dk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pedersen</LastName>
<ForeName>Erling M</ForeName>
<Initials>EM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rwegoshora</LastName>
<ForeName>Rwehumbiza T</ForeName>
<Initials>RT</Initials>
</Author>
<Author ValidYN="Y"><LastName>Malecela</LastName>
<ForeName>Mwelecele N</ForeName>
<Initials>MN</Initials>
</Author>
<Author ValidYN="Y"><LastName>Derua</LastName>
<ForeName>Yahya A</ForeName>
<Initials>YA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Magesa</LastName>
<ForeName>Stephen M</ForeName>
<Initials>SM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2010</Year>
<Month>06</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS Negl Trop Dis</MedlineTA>
<NlmUniqueID>101291488</NlmUniqueID>
<ISSNLinking>1935-2727</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000977">Antiparasitic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>70288-86-7</RegistryNumber>
<NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>F4216019LN</RegistryNumber>
<NameOfSubstance UI="D015766">Albendazole</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Allergy. 1993 Apr;48(3):207-8</RefSource>
<PMID Version="1">8506990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):94-7</RefSource>
<PMID Version="1">9692166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Expert Opin Pharmacother. 2005 Feb;6(2):179-200</RefSource>
<PMID Version="1">15757416</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2000 Jul-Aug;94(4):437-43</RefSource>
<PMID Version="1">11127253</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009 Aug 25;3(8):e412</RefSource>
<PMID Version="1">19707588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1995 Dec;89(6):653-63</RefSource>
<PMID Version="1">8745940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitol Today. 2000 Jul;16(7):298-302</RefSource>
<PMID Version="1">10858649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1979 Oct;73(5):457-64</RefSource>
<PMID Version="1">393190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):189-92</RefSource>
<PMID Version="1">12055812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2005 Apr;99(3):253-65</RefSource>
<PMID Version="1">15829135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010;4(2):e602</RefSource>
<PMID Version="1">20169115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 1995 Dec;60(3):179-87</RefSource>
<PMID Version="1">8907396</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Expert Rev Anti Infect Ther. 2009 Jun;7(5):595-605</RefSource>
<PMID Version="1">19485799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:395-441</RefSource>
<PMID Version="1">16735170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009 Aug 25;3(8):e443</RefSource>
<PMID Version="1">19707279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008;2(10):e317</RefSource>
<PMID Version="1">18841205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2007 Dec;77(6):1069-73</RefSource>
<PMID Version="1">18165524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1997 Aug 16;350(9076):480-4</RefSource>
<PMID Version="1">9274584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 1997 Feb;2(2):153-8</RefSource>
<PMID Version="1">9472300</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2009 Jul;25(7):319-27</RefSource>
<PMID Version="1">19559649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Oct;79(4):480-4</RefSource>
<PMID Version="1">18840733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 Nov 1;372(9649):1555-62</RefSource>
<PMID Version="1">18984188</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):205-11</RefSource>
<PMID Version="1">10897370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2004 Aug;98(8):462-72</RefSource>
<PMID Version="1">15186934</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Jun;78(6):924-8</RefSource>
<PMID Version="1">18541771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2004 Jan;70(1):63-71</RefSource>
<PMID Version="1">14971700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2006 Nov;22(11):529-35</RefSource>
<PMID Version="1">16971182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2001 May-Jun;95(3):332-5</RefSource>
<PMID Version="1">11491010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Feb;78(2):283-8</RefSource>
<PMID Version="1">18256430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Mar 25;367(9515):992-9</RefSource>
<PMID Version="1">16564361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitology. 2000;121 Suppl:S147-60</RefSource>
<PMID Version="1">11386686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2004 Apr;4(4):223-34</RefSource>
<PMID Version="1">15050941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2002 May;66(5):550-9</RefSource>
<PMID Version="1">12201589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008;2(12):e344</RefSource>
<PMID Version="1">19065257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2005 Aug;5(8):514-23</RefSource>
<PMID Version="1">16048720</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000977" MajorTopicYN="N">Antiparasitic Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008842" MajorTopicYN="N">Microfilariae</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013636" MajorTopicYN="N">Tanzania</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC2879369</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year>
<Month>10</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2010</Year>
<Month>04</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>6</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>6</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20532226</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pntd.0000696</ArticleId>
<ArticleId IdType="pmc">PMC2879369</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Danemark</li>
</country>
</list>
<tree><noCountry><name sortKey="Derua, Yahya A" sort="Derua, Yahya A" uniqKey="Derua Y" first="Yahya A" last="Derua">Yahya A. Derua</name>
<name sortKey="Magesa, Stephen M" sort="Magesa, Stephen M" uniqKey="Magesa S" first="Stephen M" last="Magesa">Stephen M. Magesa</name>
<name sortKey="Malecela, Mwelecele N" sort="Malecela, Mwelecele N" uniqKey="Malecela M" first="Mwelecele N" last="Malecela">Mwelecele N. Malecela</name>
<name sortKey="Pedersen, Erling M" sort="Pedersen, Erling M" uniqKey="Pedersen E" first="Erling M" last="Pedersen">Erling M. Pedersen</name>
<name sortKey="Rwegoshora, Rwehumbiza T" sort="Rwegoshora, Rwehumbiza T" uniqKey="Rwegoshora R" first="Rwehumbiza T" last="Rwegoshora">Rwehumbiza T. Rwegoshora</name>
</noCountry>
<country name="Danemark"><noRegion><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002814 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002814 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:20532226
   |texte=   Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:20532226" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki